Matti Narkia's Library tagged → View Popular
NEJM -- Fish Consumption and the 30-Year Risk of Fatal Myocardial Infarction
Fish consumption and the 30-year risk of fatal myocardial infarction.
Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB.
N Engl J Med. 1997 Apr 10;336(15):1046-53.
PMID: 9091800
Conclusions These data show an inverse association between fish consumption and death from coronary heart disease, especially nonsudden death from myocardial infarction.
NEJM -- Mercury, Fish Oils, and the Risk of Myocardial Infarction
Mercury, fish oils, and the risk of myocardial infarction.
Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gómez-Aracena J, Kark JD, Riemersma RA, Martín-Moreno JM, Kok FJ; Heavy Metals and Myocardial Infarction Study Group.
N Engl J Med. 2002 Nov 28;347(22):1747-54.
PMID: 12456850
Conclusions The toenail mercury level was directly associated with the risk of myocardial infarction, and the adipose-tissue DHA level was inversely associated with the risk. High mercury content may diminish the cardioprotective effect of fish intake.
NEJM -- Mercury and the Risk of Coronary Heart Disease in Men
Mercury and the risk of coronary heart disease in men.
Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, Stampfer MJ, Willett WC.
N Engl J Med. 2002 Nov 28;347(22):1755-60.
PMID: 12456851
Conclusions Our findings do not support an association between total mercury exposure and the risk of coronary heart disease, but a weak relation cannot be ruled out.
NEJM -- Low-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women
Low-carbohydrate-diet score and the risk of coronary heart disease in women.
Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB.
N Engl J Med. 2006 Nov 9;355(19):1991-2002.
PMID: 17093250
Conclusions Our findings suggest that diets lower in carbohydrate and higher in protein and fat are not associated with increased risk of coronary heart disease in women. When vegetable sources of fat and protein are chosen, these diets may moderately reduce the risk of coronary heart disease.
Vitamin D Newsletter Mar 2006 | Dr. Wactawski-Wende, New England Journal of Medicine, and Ethics
"Good research is good for medicine. The only thing more important than good research is ethical research. The February 16th issue of the New England Journal of Medicine (NEJM) had a research paper on vitamin D and colon cancer. Was it good research? Was it ethical research? At stake are the lives of 36,000 older American women who agreed to participate in the Women's Health Initiative. "
NEJM -- Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Coronary calcium as a predictor of coronary events in four racial or ethnic groups.
Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA.
N Engl J Med. 2008 Mar 27;358(13):1336-45.
PMID: 18367736
NEJM -- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group.
N Engl J Med. 2008 Jul 17;359(3):229-41.
PMID: 18635428
Conclusions Mediterranean and low-carbohydrate diets may be effective alternatives to low-fat diets. The more favorable effects on lipids (with the low-carbohydrate diet) and on glycemic control (with the Mediterranean diet) suggest that personal preferences and metabolic considerations might inform individualized tailoring of dietary interventions. (ClinicalTrials.gov number, NCT00160108 [ClinicalTrials.gov] .)
NEJM -- Vitamin D3 and calcium to prevent hip fractures in the elderly women
Vitamin D3 and calcium to prevent hip fractures in the elderly women.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ.
N Engl J Med. 1992 Dec 3;327(23):1637-42.
PMID: 1331788
CONCLUSIONS. Supplementation with vitamin D3 and calcium reduces the risk of hip fractures and other nonvertebral fractures among elderly women.
NEJM -- Vitamin D Intoxication Associated with an Over-the-Counter Supplement
Vitamin D intoxication associated with an over-the-counter supplement.
Koutkia P, Chen TC, Holick MF.
N Engl J Med. 2001 Jul 5;345(1):66-7.
PMID: 11439958
NEJM -- Improved Mineral Balance and Skeletal Metabolism in Postmenopausal Women Treated with Potassium Bicarbonate
Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris RC Jr.
Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.
N Engl J Med. 1994 Jun 23;330(25):1776-81.
PMID: 8190153 [PubMed - indexed for MEDL
NEJM -- Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Calcium plus vitamin D supplementation and the risk of colorectal cancer.
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE; Women's Health Initiative Investigators.
N Engl J Med. 2006 Feb 16;354(7):684-96. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.
PMID: 16481636
Conclusions Daily supplementation of calcium with vitamin D for seven years had no effect on the incidence of colorectal cancer among postmenopausal women. The long latency associated with the development of colorectal cancer, along with the seven-year duration of the trial, may have contributed to this null finding. Ongoing follow-up will assess the longer-term effect of this intervention.
NEJM -- Vitamin D3 and calcium to prevent hip fractures in the elderly women
Vitamin D3 and calcium to prevent hip fractures in the elderly women.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ.
N Engl J Med. 1992 Dec 3;327(23):1637-42.
PMID: 1331788
CONCLUSIONS. Supplementation with vitamin D3 and calcium reduces the risk of hip fractures and other nonvertebral fractures among elderly women.
NEJM -- Hypovitaminosis D in Medical Inpatients
Hypovitaminosis D in medical inpatients.
Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS.
N Engl J Med. 1998 Mar 19;338(12):777-83.
PMID: 9504937
Conclusions Hypovitaminosis D is common in general medical inpatients, including those with vitamin D intakes exceeding the recommended daily amount and those without apparent risk factors for vitamin D deficiency.
NEJM -- Expanding the Orbit of Primary Prevention -- Moving beyond JUPITER
Expanding the orbit of primary prevention--moving beyond JUPITER.
Hlatky MA.
N Engl J Med. 2008 Nov 20;359(21):2280-2. Epub 2008 Nov 9. No abstract available.
PMID: 18997195
NEJM -- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Conclusions For patients with coronary artery disease, the reduced rate of progression of atherosclerosis associated with intensive statin treatment, as compared with moderate statin treatment, is significantly related to greater reductions in the levels of both atherogenic lipoproteins and CRP.
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.
N Engl J Med. 2005 Jan 6;352(1):29-38.
PMID: 15635110
NEJM -- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
Conclusions C-reactive protein is a relatively moderate predictor of coronary heart disease. Recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V.
N Engl J Med. 2004 Apr 1;350(14):1387-97.
PMID: 15070788
NEJM -- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
Conclusions The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.
N Engl J Med. 1997 Apr 3;336(14):973-9. Erratum in: N Engl J Med 1997 Jul 31;337(5):356.
PMID: 9077376
NEJM -- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Conclusions Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.
Inflammatory markers and the risk of coronary heart disease in men and women.
Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB.
N Engl J Med. 2004 Dec 16;351(25):2599-610.
NEJM -- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Conclusions In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence of major cardiovascular events.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.
N Engl J Med. 2008 Nov 20;359(21):2195-207. Epub 2008 Nov 9.
PMID: 18997196
NEJM -- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Conclusions These data suggest that the C-reactive protein level is a stronger predictor of cardiovascular events than the LDL cholesterol level and that it adds prognostic information to that conveyed by the Framingham risk score.
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR.
N Engl J Med. 2002 Nov 14;347(20):1557-65.
PMID: 12432042
Selected Tags
Related Tags
Sponsored Links
Top Contributors
Groups interested in NEJM
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo
